Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant.

Qiyuan Chen; Heather Jackson; Phillip Parente; Tina Luke; Mark Rizkalla; Tsin Yee Tai; He-Cheng Zhu; Nicole A Mifsud; Nektaria Dimopoulos; Kelly-Anne Masterman

doi:10.1073/pnas.0403271101

Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant.

Identifier:nobleid.org/w1/20260515/0ABCE871

Type:Conference Paper

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0ABCE871.svg?ark=w1%2F20260515%2F0ABCE871)](https://nobleid.org/work/w1/20260515/0ABCE871)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant.

Identifier:nobleid.org/w1/20260515/0ABCE871

Type:Conference Paper

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0ABCE871.svg?ark=w1%2F20260515%2F0ABCE871)](https://nobleid.org/work/w1/20260515/0ABCE871)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work